1. A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice. Issue 5 (29th January 2020) Authors: Sesti, Giorgio; Bardtrum, Lars; Dagdelen, Selcuk; Halladin, Natalie; Haluzík, Martin; Őrsy, Petra; Rodríguez, Martin; Aroda, Vanita R. Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 5(2020) Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial. Issue 8 (August 2019) Authors: Aroda, Vanita R; González-Galvez, Guillermo; Grøn, Randi; Halladin, Natalie; Haluzík, Martin; Jermendy, György; Kok, Adri; Őrsy, Petra; Sabbah, Mohamed; Sesti, Giorgio; Silver, Robert Journal: Lancet Issue: Volume 7:Issue 8(2019) Page Start: 596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial. Issue 6 (3rd March 2017) Authors: Harris, Stewart B.; Kocsis, Győző; Prager, Rudolf; Ridge, Terry; Chandarana, Keval; Halladin, Natalie; Jabbour, Serge Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 6(2017) Page Start: 858 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes. Issue 6 (4th April 2019) Authors: Philis‐Tsimikas, Athena; Billings, Liana K.; Busch, Robert; Portillo, Cristobal Morales; Sahay, Rakesh; Halladin, Natalie; Eggert, Sarah; Begtrup, Kamilla; Harris, Stewart Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 6(2019) Page Start: 1399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial. (May 2021) Authors: Billings, Liana K.; Agner, Bue F. Ross; Altuntas, Yuksel; Grøn, Randi; Halladin, Natalie; Klonoff, David C.; Tentolouris, Nikolaos; Jódar, Esteban Journal: Journal of diabetes science and technology Issue: Volume 15:Number 3(2021) Page Start: 636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗